USE OF DL-(+/-)-.ALPHA.-LIPOIC ACID, D-(+)-.ALPHA.-LIPOIC ACID, .ALPHA.-LIPOIC ACID IN REDUCED OR OXIDIZED FORM OR SALTS FOR TREATING CIRCULATORY DISORDERS

摘要

The invention relates to the use of DL-(+/-)-.alpha. lipoic acid, D(+)-.alpha.-lipoic acid, L-(-)-.alpha.-lipoic acid in reduced or oxidised form or of the metabolites and salts, esters, amides thereof for the preparation of medicines for the treatment of disorders caused by changes or disturbances in the rheological properties of the blood such as blood viscosity, erythrocyte flexibility and the aggregation of erythrocytes, in particular for the treatment of microangiopathy with disturbed microcirculation. It can be used in particular in the treatment of diabetics and of dialysis patients for protection of the erythrocytes, in central and peripheral circulatory disturbances and in tinnitus and hearing loss.